Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Establishment and Drug Sensitivity, Gene Expression and Epigenetic Characterization of a Pediatric Leukemia Cell Line (POETIC1) with Primary Resistance to Decitabine

Maneka Perinpanayagam, PhD, Anna Kovalchuk, Yibing Ruan, PhD, Sungmyung Kang, Aarthi Jayanthan, Olga Kovalchuk, Jessica Boklan, MD, Aru Narendran, MD PhD

Blood (2014) 124 (21): 983.

https://doi.org/10.1182/blood.V124.21.983.983

Published: 2014

Journal Articles

I n Vitro Growth Inhibition, Target Modulation and Drug Synergy In Pediatric Leukemia By The Novel Proteasome Inhibitor Carfilzomib

Aarthi Jayanthan, Yibing Ruan, PhD, Meaghan Hagerty, Ravi Shah, Tony Truong, MD, Victor A. Lewis, MD, Jessica Boklan, MD, Tanya Trippett, MD, Lia Gore, MD, Aru Narendran, MD, PhD

Blood (2013) 122 (21): 2673.

https://doi.org/10.1182/blood.V122.21.2673.2673

Published: 2013

Journal Articles

Cooperative Lethality of Polo-Like Kinases (PLK) and Aurora Kinases (AK) in Refractory Pediatric Leukemia

Aarthi Jayanthan, Todd Cooper, DO, Sandra E. Dunn, PhD, Victor A. Lewis, MD, Aru Narendran, MD, PhD

Blood (2012) 120 (21): 3573.

https://doi.org/10.1182/blood.V120.21.3573.3573

Published: 2012

Journal Articles

Preclinical Studies of Cytotoxicity, Drug Synergy and Biological Correlates of Clofarabine Against Infant Leukemia Cells

Aarthi Jayanthan, Anjali Singh, Victor A Lewis, MD, Aru Narendran, MD, PhD

Blood (2010) 116 (21): 4342.

https://doi.org/10.1182/blood.V116.21.4342.4342

Published: 2010

Journal Articles

AT9283, A Novel Aurora Kinase/Jak2 Inhibitor Demonstrates Activity against Refractory Infant Leukemia Cells: Studies On Growth Inhibition, Biological Correlates, Drug Synergy and Effects On Leukemia Stem-Like Cells.

Shamim Lotfi, MS, Aarthi Jayanthan, BS, Victor A. Lewis, MD, Greg Guilcher, MD, Matthew S Squires, PhD, Todd Cooper, DO, Aru Narendran, MD., Ph.D

Blood (2009) 114 (22): 3078.

https://doi.org/10.1182/blood.V114.22.3078.3078

Published: 2009

Journal Articles

Targeting the Bcl-2 Family of Proteins in Hodgkin Lymphoma: In Vitro Cytotoxicity, Target Modulation and Drug Combination Studies of the BH3 Mimetic ABT-737

Aarthi Jayanthan, BS, Scott C Howard, MD, Tanya Trippett, MD, Terzah M. Horton, MD, PhD, Lara Daisley, Victor A. Lewis, MD, Aru Narendran, MD., Ph.D

Blood (2008) 112 (11): 3626.

https://doi.org/10.1182/blood.V112.11.3626.3626

Published: 2008

NARROW

Establishment and Drug Sensitivity, Gene Expression and Epigenetic Characterization of a Pediatric Leukemia Cell Line (POETIC1) with Primary Resistance to Decitabine

I n Vitro Growth Inhibition, Target Modulation and Drug Synergy In Pediatric Leukemia By The Novel Proteasome Inhibitor Carfilzomib

Cooperative Lethality of Polo-Like Kinases (PLK) and Aurora Kinases (AK) in Refractory Pediatric Leukemia

Preclinical Studies of Cytotoxicity, Drug Synergy and Biological Correlates of Clofarabine Against Infant Leukemia Cells

AT9283, A Novel Aurora Kinase/Jak2 Inhibitor Demonstrates Activity against Refractory Infant Leukemia Cells: Studies On Growth Inhibition, Biological Correlates, Drug Synergy and Effects On Leukemia Stem-Like Cells.

Targeting the Bcl-2 Family of Proteins in Hodgkin Lymphoma: In Vitro Cytotoxicity, Target Modulation and Drug Combination Studies of the BH3 Mimetic ABT-737

Email alerts

ASH Publications

American Society of Hematology

Establishment and Drug Sensitivity, Gene Expression and Epigenetic Characterization of a Pediatric Leukemia Cell Line (POETIC1) with Primary Resistance to Decitabine

I n Vitro Growth Inhibition, Target Modulation and Drug Synergy In Pediatric Leukemia By The Novel Proteasome Inhibitor Carfilzomib

Cooperative Lethality of Polo-Like Kinases (PLK) and Aurora Kinases (AK) in Refractory Pediatric Leukemia

Preclinical Studies of Cytotoxicity, Drug Synergy and Biological Correlates of Clofarabine Against Infant Leukemia Cells

AT9283, A Novel Aurora Kinase/Jak2 Inhibitor Demonstrates Activity against Refractory Infant Leukemia Cells: Studies On Growth Inhibition, Biological Correlates, Drug Synergy and Effects On Leukemia Stem-Like Cells.

Targeting the Bcl-2 Family of Proteins in Hodgkin Lymphoma: In Vitro Cytotoxicity, Target Modulation and Drug Combination Studies of the BH3 Mimetic ABT-737

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only